Suchergebnisse - "Othman, Ahmed A"

PubPharm (310)

91

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

enthalten in: Europäisches Patentamt | 2021

von ALLIAN AYMAN | JAYANTH JAYANTHY | MOHAMED MOHAMED-ESLAM F | +10

92

METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS

enthalten in: Europäisches Patentamt | 2021

von THAKKAR ROOPAL B | JUNGERWIRTH STEVEN | MACHADO DE LACERDA ANA PAULA | +7

93

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

enthalten in: Europäisches Patentamt | 2021

von ALLIAN AYMAN | JAYANTH JAYANTHY | MOHAMED MOHAMED-ESLAM F | +10

94

Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects

enthalten in: Clinical pharmacology in drug development | 2021

von Mohamed, M. | Coppola, S. | Feng, T. | +3

95

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

enthalten in: Europäisches Patentamt | 2021

von ALLIAN AYMAN | JAYANTH JAYANTHY | MOHAMED MOHAMED-ESLAM F | +10

96

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

enthalten in: Europäisches Patentamt | 2021

von ALLIAN AYMAN | JAYANTH JAYANTHY | MOHAMED MOHAMED-ESLAM F | +10

97

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-A]PYRROLO[2,3-E]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

enthalten in: Europäisches Patentamt | 2021

von ALLIAN AYMAN D | JAYANTH JAYANTHY | MOHAMED MOHAMED-ESLAM F | +10

98

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

enthalten in: Europäisches Patentamt | 2021

von BHAGAVATULA LAKSHMI | MARROUM PATRICK J | ALLIAN AYMAN D | +10

99

Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 Doses

enthalten in: Journal of clinical pharmacology | 2021

von Mohamed, M. | Gopalakrishnan, S. | Teixeira, H. | +1

100

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof

enthalten in: Europäisches Patentamt | 2021

von PANGAN AILEEN L | TEIXEIRA HENRIQUE D | MOHAMED MOHAMED-ESLAM F | +2